Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

All for one, one for all: new combinatorial RNAi therapies combat hepatitis C virus evolution.

Grimm D.

Mol Ther. 2012 Sep;20(9):1661-3. doi: 10.1038/mt.2012.173. No abstract available.

2.

Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes.

Chandra PK, Kundu AK, Hazari S, Chandra S, Bao L, Ooms T, Morris GF, Wu T, Mandal TK, Dash S.

Mol Ther. 2012 Sep;20(9):1724-36. doi: 10.1038/mt.2012.107. Epub 2012 May 22.

3.

Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate model.

Suhy DA, Kao SC, Mao T, Whiteley L, Denise H, Souberbielle B, Burdick AD, Hayes K, Wright JF, Lavender H, Roelvink P, Kolykhalov A, Brady K, Moschos SA, Hauck B, Zelenaia O, Zhou S, Scribner C, High KA, Renison SH, Corbau R.

Mol Ther. 2012 Sep;20(9):1737-49. doi: 10.1038/mt.2012.119. Epub 2012 Jun 26.

4.

Potential applications of siRNA in hepatitis C virus therapy.

Smolic R, Volarevic M, Wu CH, Wu GY.

Curr Opin Investig Drugs. 2006 Feb;7(2):142-6. Review.

PMID:
16499284
5.

In vivo therapeutic potential of Dicer-hunting siRNAs targeting infectious hepatitis C virus.

Watanabe T, Hatakeyama H, Matsuda-Yasui C, Sato Y, Sudoh M, Takagi A, Hirata Y, Ohtsuki T, Arai M, Inoue K, Harashima H, Kohara M.

Sci Rep. 2014 Apr 23;4:4750. doi: 10.1038/srep04750.

6.

Opportunities for treating chronic hepatitis B and C virus infection using RNA interference.

Arbuthnot P, Longshaw V, Naidoo T, Weinberg MS.

J Viral Hepat. 2007 Jul;14(7):447-59. Review.

PMID:
17576386
7.

[Using RNA interference to treat hepatitis virus: hope for future development].

Wei L.

Zhonghua Gan Zang Bing Za Zhi. 2004 Sep;12(9):555. Chinese. No abstract available.

PMID:
15387911
8.

Dynamics of hepatitis C virus replication in human liver.

Chang M, Williams O, Mittler J, Quintanilla A, Carithers RL Jr, Perkins J, Corey L, Gretch DR.

Am J Pathol. 2003 Aug;163(2):433-44.

9.

[Current Guidelines for treatment of hepatitis C. The eradication of HCV as a goal].

Sarrazin C, Zeuzem S.

Pharm Unserer Zeit. 2011 Jan;40(1):52-9. doi: 10.1002/pauz.201100400. Review. German. No abstract available.

PMID:
21194083
10.

Role of lipid infiltration of hepatocytes in the morphogenesis of chronic hepatitis C.

Nepomnyashchikh GI, Bakarev MA, Nepomnyashchikh DL, Yudanov AV, Kapustina VI, Migus'kova EI, Postnikova OA, Vinogradova EV, Nokhrina ZhV, Savchenko SA.

Bull Exp Biol Med. 2013 Dec;156(2):281-4.

PMID:
24319768
11.

[Hepatitis C virus RNA in patients with chronic hepatitis C].

Lakina EI, Kushch AA.

Vopr Virusol. 2002 Mar-Apr;47(2):4-11. Review. Russian.

PMID:
12046467
12.

Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes.

Kim SI, Shin D, Lee H, Ahn BY, Yoon Y, Kim M.

J Hepatol. 2009 Mar;50(3):479-88. doi: 10.1016/j.jhep.2008.10.029. Epub 2008 Dec 27.

PMID:
19155084
13.

Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.

Lau GK, Davis GL, Wu SP, Gish RG, Balart LA, Lau JY.

Hepatology. 1996 Jun;23(6):1318-23.

PMID:
8675145
14.

RNAi as a new therapeutic strategy against HCV.

Khaliq S, Khaliq SA, Zahur M, Ijaz B, Jahan S, Ansar M, Riazuddin S, Hassan S.

Biotechnol Adv. 2010 Jan-Feb;28(1):27-34. doi: 10.1016/j.biotechadv.2009.08.004. Review.

PMID:
19729057
15.

Hepatitis C virus and chronic liver disease.

Lemon SM, Brown EA.

Curr Clin Top Infect Dis. 1994;14:120-41. Review. No abstract available.

PMID:
8086111
16.

[Ultrastructural reactions of liver cell populations during exposure to RNA- and DNA-genomic hepatitis C+B virus].

Nepomniashchikh GI, Tolokonskaia NP, Ań≠dagulova SV, Nepomniashchikh DL, Sakharova EG, Mezentseva GA, Savchenko IaE.

Biull Eksp Biol Med. 1999 Jul;128(7):101-5. Russian. No abstract available.

PMID:
10485065
17.

Development of a novel nested in situ PCR-ISH method for detection of hepatitis C virus RNA in liver tissue.

Alzahrani AJ, Vallely PJ, McMahon RF.

J Virol Methods. 2002 Jan;99(1-2):53-61.

PMID:
11684303
18.

[HCV-RNA in liver of chronic hepatitis C--plus strand RNA and minus strand RNA].

Endo H, Yamada G.

Nihon Rinsho. 1995 Sep;53 Suppl(Pt 1):623-8. Review. Japanese. No abstract available.

PMID:
7563844
19.

Structural and functional features of lipid-containing hepatocytes in hepatitis C.

Nepomnyashchikh GI, Postnikova OA, Bakarev MA, Nepomnyashchikh DL, Kapustina VI.

Bull Exp Biol Med. 2012 Sep;153(5):787-90.

PMID:
23113286
20.

[Change of HCV-RNA levels in liver tissue and interferon responsiveness in patients with chronic hepatitis C].

Takeuchi M, Kaneko S, Unoura M, Kobayashi K.

Nihon Rinsho. 1995 Sep;53 Suppl(Pt 1):969-74. Japanese. No abstract available.

PMID:
7563912

Supplemental Content

Support Center